Jayakumar Jerobin
Overview
Explore the profile of Jayakumar Jerobin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdulla A, Sadida H, Jerobin J, Elfaki I, Mir R, Mirza S, et al.
J Natl Cancer Cent
. 2025 Mar;
5(1):8-27.
PMID: 40040878
Obesity, a global health concern, is associated with severe health issues like type 2 diabetes, heart disease, and respiratory complications. It also increases the risk of various cancers, including melanoma,...
2.
Alser M, Ramanjaneya M, Anwardeen N, Donati F, Botre F, Jerobin J, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(5):181.
PMID: 39077591
Background: Humanin and the mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) are mitochondrial encoded peptides involved in energy metabolism, cytoprotection, longevity, insulin sensitivity and their expression decrease with...
3.
AlMarzooqi S, Almarzooqi F, Sadida H, Jerobin J, Ahmed I, Abou-Samra A, et al.
Obes Rev
. 2024 May;
25(8):e13766.
PMID: 38745386
Obesity stands as a formidable global health challenge, predisposing individuals to a plethora of chronic illnesses such as cardiovascular disease, diabetes, and cancer. A confluence of genetic polymorphisms, suboptimal dietary...
4.
Kumar M, Baba S, Sadida H, Al Marzooqi S, Jerobin J, Altemani F, et al.
Signal Transduct Target Ther
. 2024 Feb;
9(1):27.
PMID: 38311623
Extracellular vesicles (EVs) are nano-sized, membranous structures secreted into the extracellular space. They exhibit diverse sizes, contents, and surface markers and are ubiquitously released from cells under normal and pathological...
5.
Jerobin J, Ali R, Khalil S, Ramanjaneya M, Betahi I, Abou Samra A, et al.
Qatar Med J
. 2023 Nov;
2023(2):20.
PMID: 38025335
Chronic Urticaria (CU) is a complex skin disease that appears as recurrent raised itchy rash/angioedema or both for more than six weeks. The pathophysiology of CU is complex and has...
6.
Bettahi I, Krishnankutty R, Jaganjac M, Suleiman N, Ramanjaneya M, Jerobin J, et al.
Front Endocrinol (Lausanne)
. 2023 Mar;
13:1024832.
PMID: 36876056
Background: Skeletal muscle is the main site for insulin-dependent glucose disposal. The hyperinsulinemic euglycemic clamp (HIEC) is the gold standard for the assessment of insulin sensitivity (IS). We have previously...
7.
Ramanjaneya M, Priyanka R, Bensila M, Jerobin J, Pawar K, Sathyapalan T, et al.
Front Endocrinol (Lausanne)
. 2022 Aug;
13:917041.
PMID: 36017315
Objective: Hypoglycemia in type 2 diabetes (T2D) increases morbidity and mortality but the underlying physiological response is still not fully understood, though physiological changes are still apparent 24 hours after...
8.
Mohammed-Ali R, Jerobin J, Khalil S, Sivaraman S, Ramanjaneya M, Betahi I, et al.
Qatar Med J
. 2022 Aug;
2022(2):5.
PMID: 35909395
Chronic urticaria (CU) is a common and complex disorder that occurs without any identifiable provoking factor. The mechanisms underlying CU pathogenesis are still not fully understood. The autoimmune theory of...
9.
Ramanjaneya M, Abdalhakam I, Bettahi I, Bensila M, Jerobin J, Aye M, et al.
Front Endocrinol (Lausanne)
. 2022 Mar;
12:740703.
PMID: 35250845
Background: The complement system is pivotal in host defense mechanisms, protecting against pathogenic infection by regulating inflammation and cell immunity. Complement-related protein activation occurs through three distinct pathways: classical, alternative,...
10.
Ramanjaneya M, Butler A, Alkasem M, Bashir M, Jerobin J, Godwin A, et al.
Front Endocrinol (Lausanne)
. 2021 Dec;
12:781347.
PMID: 34858349
[This corrects the article DOI: 10.3389/fendo.2021.641361.].